This article was written by Follow The Investment Doctor is a financial writer, highlighting European small-caps with a 5-7 year investment horizon. He strongly...
This article was written by Follow The Investment Doctor is a financial writer, highlighting European small-caps with a 5-7 year investment horizon. He strongly...
Akoustis Technologies, Inc. (NASDAQ:AKTS) Q4 2023 Earnings Conference Call September 6, 2023 8:00 AM ET Company Participants Tom Sepenzis – Investor Relations Jeff Shealy...
The retirement savings landscape experienced a radical transformation with the enactment of the SECURE Act 2.0 at the end of 2022. This groundbreaking legislation...
This article was written by Seeking Alpha’s transcripts team is responsible for the development of all of our transcript-related projects. We currently publish thousands...
Recombinant therapeutic protein developer, Protalix BioTherapeutics, Inc. (NYSE:PLX) reported Q2 2023 revenues of $35.08 million, representing a 300.72% (YoY) increase. It beat Wall Street...